Rossari Biotech posts 37 per cent revenue growth at Rs 218 crore; earnings per share grows to Rs 4.29 as against Rs 3.06
Speciality chemicals manufacturer Rossari Biotech has posted 37 per cent increase in its revenues from operations during the quarter ended March at Rs 218 crore as against Rs 160 crore in the year-ago period.
Rossari Biotech expects to sustainably ramp up utilisation levels at the Dahej unit over the next three to four years. Source: Company Website